Navigation Links
Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/7/2008

PT. RICHMOND, Calif., Feb. 7 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, Chief Executive Officer & President, will present at the 10th Annual BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Tuesday, February 12, 2008 at 10:15 AM Eastern Time.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. Transcept development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Phase 3 clinical trials have been completed for Intermezzo(R) and Transcept plans to submit an NDA in the third quarter of 2008. Another product being developed by Transcept is TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. TO-2060 has recently completed a successful dose ranging trial for the treatment of alcohol use disorder and a full clinical development program has begun. For further information, please visit the company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc.

Michael Gill

Director of Communications

(510) 215-3575

mgill@transcept.com

The Ruth Group

Investors / Media

Stephanie Carrington / Jason Rando

(646) 536-7017 / 7025

scarrington@theruthgroup.com

jrando@theruthgroup
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
5. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2014)... and those affected by one often feel that their ... after a stroke is therefore about reestablishing life as ... rarely possible and thus a source of frustration for ... Copenhagen who has interviewed a number of patients experiencing ... thesis was carried out in collaboration with a Danish ...
(Date:3/14/2014)... admitted to hospital with blood poisoning, while more than ... research shows that Danes suffering from blood poisoning risk ... risk of suffering a blood clot:, "We have followed ... blood poisoning. The study shows that the risk of ... the heart is twice as high for patients with ...
(Date:3/14/2014)... HOUSTON (March 13, 2014) Open, feed, cut. Such is ... new research at Rice University, that eats and excretes damaged ... The why is obvious: Without these trash bins, the ... to Rice, the how is becoming clearer. , Biophysicists at ... FtsH-AAA hexameric peptidase as a model to test calculations ...
(Date:3/14/2014)... in Annals of Surgical Oncology , clinicians worked ... to conclude there was a time-dependent link between being ... review of 88 international studies to date, is the ... Nikfarjam, liver, pancreas and biliary specialist from the Department ... cancer was often diagnosed when at an advanced, incurable ...
(Date:3/13/2014)... health appear crucial to preventing conflict among older couples ... a study from University of Chicago researchers. , The ... of a role in limiting marital conflict, perhaps because ... relationships. , "Wives report more conflict if their husband ... James Iveniuk, PhD candidate in the Department of Sociology. ...
Breaking Medicine News(10 mins):Health News:Stroke patients may benefit from new routines 2Health News:New knowledge: Blood poisoning increases the risk of blood clots 2Health News:Big data tackles tiny molecular machines 2Health News:Big data tackles tiny molecular machines 3Health News:Husband's health and attitude loom large for happy long-term marriages 2
... Center Utrecht, the Netherlands, have discovered a substance that has ... making cancer cells insensitive to the treatment. Chemotherapy often loses ... this happens. It now appears that chemotherapy is ... made by stem cells in the blood. Under the influence ...
... new study published in The Journal of Sexual Medicine ... vagina, cervix, or clitoris was shown to activate three ... sexuality experts have claimed that the major source of ... sensation produced by vaginal or cervical stimulation., Researchers led ...
... a high-fat diet isn,t healthy. Now researchers have discovered ... Writing in the Journal of Biological Chemistry, ... Medicine and director of the Institute for Diabetes, Obesity, ... the University of Pennsylvania, and colleagues, describe that mice ...
... Mozes HealthDay Reporter , SUNDAY, Sept. 11 (HealthDay ... the bombing of Pearl Harbor still packs a psychological punch ... point, it serves as the moment when a stunned young ... the world stage with the now-iconic can-do bravado of the ...
... Sept. 11, 2011 -- Researchers at the Hebrew University ... production of insulin-producing beta cells in the pancreas -- ... ways to restore or increase beta cell function in ... on the multi-year project was led by Prof. Yuval ...
... used to avoid hazardous waste being dumped where it ... Introducing producer responsibility could be one solution, says Panate ... (IIIEE) at Lund University, Sweden, in a new thesis. ... and electronic equipment (WEEE) in China, India and various ...
Cached Medicine News:Health News:Fish oil reduces effectiveness of chemotherapy 2Health News:Stimulation of female genital regions produces strong activation of various brain sites 2Health News:High-fat diet and lack of enzyme can lead to heart disease in mice 2Health News:9/11 Left Permanent Scars on the American Psyche 2Health News:9/11 Left Permanent Scars on the American Psyche 3Health News:9/11 Left Permanent Scars on the American Psyche 4Health News:9/11 Left Permanent Scars on the American Psyche 5Health News:9/11 Left Permanent Scars on the American Psyche 6Health News:Key signal that prompts production of insulin-producing beta cells points way toward diabetes cure 2Health News:Producer responsibility solution to electronic waste in developing countries 2Health News:Producer responsibility solution to electronic waste in developing countries 3
(Date:1/15/2014)... BOSTON , Jan. 15, 2014 Tegra ... Mr. J. Mark King as its new ... role of Chief Operating Officer, in which he has ... , Mississippi , and Costa ... 20+ years of broad-based operations, sales, engineering and manufacturing ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... market research report is available in its ... Market & Forecast – Worldwide Analysis ... Insulin Pump Market Analysis ... in the market as insulin delivery systems ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ... fat content and preserved lean body mass following ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... WASHINGTON, April 5, 2011 The American Center for Law ... sweeping victory for pro-life pharmacy owners in Illinois after a ... today issued a decision striking down a state law that ... of emergency contraception, even if doing so violates their religious ...
... April 5, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... that the Company intends to release its first quarter 2011 ... open of the U.S. financial markets.  The Company will also ... Time on April 27, 2011 to discuss its financial results ...
Cached Medicine Technology:ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle 2ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle 3Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2
... has been a key participant in the ... than a decade. Previous Medtronic autotransfusion systems ... platelets, as well as to determine requirements ... platelet-rich plasma (PRP) for a small amount ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... System combines low-profile, high radial force, and excellent ... compatible stent system provides 6F sheath / 8F ... 10.0 mm). Now, with longer stents available, the ... lengths (28, 38, 56, 80 and 100 mm) ...
... Supreme and Response catheters comprise the ... available for electrophysiology procedures. Their advanced ... for superior torque response with a ... curves and French sizes, Supreme and ...
Medicine Products: